Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 3
1(25.0%)
Phase 2
1(25.0%)
4Total
Phase 4(2)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT06898723Phase 4Recruiting

The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis

Role: collaborator

NCT05159947Phase 3Unknown

SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial

Role: collaborator

NCT04126382Phase 2Unknown

LISA vs INSURE in the Treatment of Respiratory Distress Syndrome in Preterm Infants

Role: collaborator

All 4 trials loaded